|
| 36824922 | Association of Polygenic Score and the involvement of Cholinergic and Glutamatergic Pathways with Lithium Treatment Response in Patients with Bipolar Disorder. | Res Sq | 2023 |
| 38077040 | Exploring the genetics of lithium response in bipolar disorders. | Res Sq | 2023 |
| 37886563 | Lithium Response in Bipolar Disorder is Associated with Focal Adhesion and PI3K-Akt Networks: A Multi-omics Replication Study. | Res Sq | 2023 |
| 37115542 | Treatment of US Children With Attention-Deficit/Hyperactivity Disorder in the Adolescent Brain Cognitive Development Study. | JAMA Netw Open | 2023 |
| 37433967 | Association of polygenic score and the involvement of cholinergic and glutamatergic pathways with lithium treatment response in patients with bipolar disorder. | Mol Psychiatry | 2023 |
| 37461719 | Immunogenetics of lithium response and psychiatric phenotypes in patients with bipolar disorder. | Res Sq | 2023 |
| 35225756 | Using polygenic scores and clinical data for bipolar disorder patient stratification and lithium response prediction: machine learning approach. | Br J Psychiatry | 2022 |
| 35505515 | Using polygenic scores and clinical data for bipolar disorder patient stratification and lithium response prediction: machine learning approach - CORRIGENDUM. | Br J Psychiatry | 2022 |
| 35817769 | Correction: Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients. | Transl Psychiatry | 2022 |
| 34845190 | Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients. | Transl Psychiatry | 2021 |
| 36408127 | Association of Attention-Deficit/Hyperactivity Disorder and Depression Polygenic Scores with Lithium Response: A Consortium for Lithium Genetics Study. | Complex Psychiatry | 2021 |
| 34497278 | HLA-DRB1 and HLA-DQB1 genetic diversity modulates response to lithium in bipolar affective disorders. | Sci Rep | 2021 |
| 32612257 | Citalopram-induced pathways regulation and tentative treatment-outcome-predicting biomarkers in lymphoblastoid cell lines from depression patients. | Transl Psychiatry | 2020 |
| 29956436 | Investigating polygenic burden in age at disease onset in bipolar disorder: Findings from an international multicentric study. | Bipolar Disord | 2019 |
| 29121268 | Association of Polygenic Score for Schizophrenia and HLA Antigen and Inflammation Genes With Response to Lithium in Bipolar Affective Disorder: A Genome-Wide Association Study. | JAMA Psychiatry | 2018 |
| 29904359 | Analysis of the Influence of microRNAs in Lithium Response in Bipolar Disorder. | Front Psychiatry | 2018 |
| 28291260 | Gene expression and proliferation biomarkers for antidepressant treatment resistance. | Transl Psychiatry | 2017 |
| 26806518 | Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study. | Lancet | 2016 |
| 27329760 | Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder. | Hum Mol Genet | 2016 |
| 27311559 | Delayed diagnosis in a house of correction: Smith-Magenis syndrome due to a de novo nonsense RAI1 variant. | Am J Med Genet A | 2016 |
| 24393808 | RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms and GTPase binding in bipolar disorder. | Mol Psychiatry | 2014 |
| 24684390 | A pilot study of plasma metabolomic patterns from patients treated with ketamine for bipolar depression: evidence for a response-related difference in mitochondrial networks. | Br J Pharmacol | 2014 |
| 24285382 | National trends in the mental health care of children, adolescents, and adults by office-based physicians. | JAMA Psychiatry | 2014 |
| 24399358 | The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. | Brain Imaging Behav | 2014 |
| 23723044 | Retention and attrition among African Americans in the STAR*D study: what causes research volunteers to stay or stray? | Depress Anxiety | 2013 |
| 24050155 | Pharmacogenetics of mood disorders: what clinicians need to know. | CNS Spectr | 2013 |
| 23827886 | Race, genetic ancestry and response to antidepressant treatment for major depression. | Neuropsychopharmacology | 2013 |
| 23840348 | Assessment of Response to Lithium Maintenance Treatment in Bipolar Disorder: A Consortium on Lithium Genetics (ConLiGen) Report. | PLoS One | 2013 |
| 22282879 | Common genetic variation in the indoleamine-2,3-dioxygenase genes and antidepressant treatment outcome in major depressive disorder. | J Psychopharmacol | 2012 |
| 22771240 | Brain-derived neurotrophic factor Val66Met polymorphism and antidepressant efficacy of ketamine in depressed patients. | Biol Psychiatry | 2012 |
| 22504417 | Identification of common variants associated with human hippocampal and intracranial volumes. | Nat Genet | 2012 |
| 22516044 | Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression. | Biol Psychiatry | 2012 |
| 20856248 | A functional alternative splicing mutation in human tryptophan hydroxylase-2. | Mol Psychiatry | 2011 |
| 21339755 | A non-synonymous polymorphism in galactose mutarotase (GALM) is associated with serotonin transporter binding potential in the human thalamus: results of a genome-wide association study. | Mol Psychiatry | 2011 |
| 21115088 | Genome-wide association studies of antidepressant outcome: a brief review. | Prog Neuropsychopharmacol Biol Psychiatry | 2011 |
| 21167476 | The Bcl-2 gene polymorphism rs956572AA increases inositol 1,4,5-trisphosphate receptor-mediated endoplasmic reticulum calcium release in subjects with bipolar disorder. | Biol Psychiatry | 2011 |
| 19236730 | Brain-derived neurotrophic factor ( BDNF) gene: no major impact on antidepressant treatment response. | Int J Neuropsychopharmacol | 2010 |
| 20981776 | Pharmacological treatment of disruptive behavior in Smith-Magenis syndrome. | Am J Med Genet C Semin Med Genet | 2010 |
| 20981775 | Autism spectrum features in Smith-Magenis syndrome. | Am J Med Genet C Semin Med Genet | 2010 |
| 20453537 | The International Consortium on Lithium Genetics (ConLiGen): an initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment. | Neuropsychobiology | 2010 |
| 20047709 | Genetic variation in HTR2A influences serotonin transporter binding potential as measured using PET and [11C]DASB. | Int J Neuropsychopharmacol | 2010 |
| 19214142 | Association study of phosphodiesterase genes in the Sequenced Treatment Alternatives to Relieve Depression sample. | Pharmacogenet Genomics | 2009 |
| 19880459 | Pharmacogenetics studies in STAR*D: strengths, limitations, and results. | Psychiatr Serv | 2009 |
| 19724244 | Genome-wide association study of suicidal ideation emerging during citalopram treatment of depressed outpatients. | Pharmacogenet Genomics | 2009 |
| 19414483 | The DISC locus and schizophrenia: evidence from an association study in a central European sample and from a meta-analysis across different European populations. | Hum Mol Genet | 2009 |
| 19295509 | Genetic and clinical predictors of sexual dysfunction in citalopram-treated depressed patients. | Neuropsychopharmacology | 2009 |
| 18191112 | The FKBP5-gene in depression and treatment response--an association study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Cohort. | Biol Psychiatry | 2008 |
| 17671280 | Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort. | Am J Psychiatry | 2007 |
| 17898344 | Genetic markers of suicidal ideation emerging during citalopram treatment of major depression. | Am J Psychiatry | 2007 |
| 17949692 | The pharmacogenetics of major depression: past, present, and future. | Biol Psychiatry | 2007 |